MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$150K
Net Income
-$46,436K
Net Profit Margin
-30957.33%
EPS
-$0.15
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenue
150
226
236*
217
Research and development
36,095
33,842
70,167*
26,821
General and administrative
12,428
11,317
12,803*
11,935
Total operating expenses
48,523
45,159
82,969*
38,756
Operating loss
-48,373
-44,933
-82,733*
-38,539
Interest income
1,938
2,327
2,935
3,258
Interest expense
1
15
-0*
2
Net loss before income taxes
-46,436
-42,621
-79,798
-35,283
Income tax expense
0
0
-62,964
560
Net loss before noncontrolling interest
-46,436
-42,621
-16,834*
-35,843
Net loss attributable to noncontrolling interest
-
-
-20,656*
-
Net loss available to class a ordinary shareholders
-
-
3,822
-
Basic EPS
-0.15
-0.14
0.028
-0.12
Diluted EPS
-0.15
-0.14
0.028
-0.12
Basic Average Shares
186,560,999
141,925,099
137,859,046
134,992,796
Diluted Average Shares
186,560,999
141,925,099
137,859,046
134,992,796
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss before
noncontrolling interest
-$46,436K
(-25.62%↓ Y/Y)
Net loss before
income taxes
-$46,436K
(-28.57%↓ Y/Y)
Interest income
$1,938K
(-46.06%↓ Y/Y)
Operating loss
-$48,373K
(-21.82%↓ Y/Y)
Revenue
$150K
(-32.13%↓ Y/Y)
Interest expense
$1K
(0.00%↑ Y/Y)
Total operating
expenses
$48,523K
(21.52%↑ Y/Y)
Research and development
$36,095K
(39.46%↑ Y/Y)
General and
administrative
$12,428K
(-11.53%↓ Y/Y)
Buy us a coffee
PROKIDNEY CORP. (PROK)
PROKIDNEY CORP. (PROK)